| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Second Department of Internal Medicine
and2 Division of Health Science, Faculty of Medicine, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113, Japan
Hepatitis C virus (HCV) populations in vivo consist of heterogeneous mixtures of genetically different but closely related variants defined as a ‘quasispecies’. The longitudinal fluctuation of HCV quasispecies populations in chronic hepatitis C has not been elucidated. Serial plasma samples were obtained from four patients with chronic hepatitis C (two patients without any treatment and two patients treated with interferon), and cDNA fragments containing the 5'-terminal region of the E2 gene of HCV were amplified from plasma RNA using PCR. Since conventional cloning of PCR products detects only a small part of the entire population, PCR products of each sample were separated by electrophoresis using single-strand conformation polymorphism (SSCP) analysis, which can distinguish DNA fragments of the same size as different electrophoretic bands depending on their sequence-specific conformation. Separated DNA fragments were recovered from SSCP bands in gels and their nucleotide sequences determined. SSCP electrophoresis separated PCR products into bands with different mobility. Sequence analysis of these bands confirmed that HCV populations in each patient are composed of quasispecies with different E2-hypervariable regions (HVR), which are known to contain antibody epitopes. Different patterns of variation in the HVR of quasispecies were observed in individual patients with different clinical features over time during chronic infection. Following interferon treatment, some quasispecies disappeared during the treatment and reappeared after the end of the treatment, whereas other quasispecies in the same patient remained during the treatment suggesting that the sensitivity to interferon is different among quasi-species.
Received 16 August 1993;
accepted 15 December 1993.
This article has been cited by other articles:
|
|
 |
|
  H. Watanabe, K. Nagayama, N. Enomoto, R. Chinzei, T. Yamashiro, N. Izumi, H. Yatsuhashi, T. Nakano, B. H. Robertson, H. Nakasone, et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease J. Gen. Virol., December 1, 2003; 84(12): 3275 - 3289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nadal, M. Martell, J. R. Lytle, A. J. Lyons, H. D. Robertson, B. Cabot, J. I. Esteban, R. Esteban, J. Guardia, and J. Gomez Specific Cleavage of Hepatitis C Virus RNA Genome by Human RNase P J. Biol. Chem., August 16, 2002; 277(34): 30606 - 30613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rubio, Y. Abou-Jawdah, H.-X. Lin, and B. W. Falk Geographically distant isolates of the crinivirus Cucurbit yellow stunting disorder virus show very low genetic diversity in the coat protein gene J. Gen. Virol., April 1, 2001; 82(4): 929 - 933. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-M. Pawlotsky, G. Germanidis, P.-O. Frainais, M. Bouvier, A. Soulier, M. Pellerin, and D. Dhumeaux Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy J. Virol., August 1, 1999; 73(8): 6490 - 6499. [Abstract] [Full Text]
|
|
|
|
|
|
S. Jang, L. Wang, M Radkowski, J Rakela, and T Laskus Differences between hepatitis C virus 5' untranslated region quasispecies in serum and liver J. Gen. Virol., March 1, 1999; 80(3): 711 - 716. [Abstract]
|
|
|
|
|
|
A Majid, P Jackson, Z Lawal, G. Pearson, H Parker, G. Alexander, J. Allain, and J Petrik Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b J. Gen. Virol., February 1, 1999; 80(2): 317 - 325. [Abstract]
|
|
|
|
 |
|
 M. Shirai, T. Arichi, M. Chen, M. Nishioka, K. Ikeda, H. Takahashi, N. Enomoto, T. Saito, M. E. Major, T. Nakazawa, et al. T Cell Recognition of Hypervariable Region-1 from Hepatitis C Virus Envelope Protein with Multiple Class II MHC Molecules in Mice and Humans: Preferential Help for Induction of Antibodies to the Hypervariable Region J. Immunol., January 1, 1999; 162(1): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Polyak, S. McArdle, S.-L. Liu, D. G. Sullivan, M. Chung, W. T. Hofgartner, R. L. Carithers Jr., B. J. McMahon, J. I. Mullins, L. Corey, et al. Evolution of Hepatitis C Virus Quasispecies in Hypervariable Region 1 and the Putative Interferon Sensitivity-Determining Region during Interferon Therapy and Natural Infection J. Virol., May 1, 1998; 72(5): 4288 - 4296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Calvo, J Kansopon, K Sra, S Quan, R DiNello, R Guaschino, G Calabrese, F Danielle, M. Brunetto, F Bonino, et al. Hepatitis C virus heteroduplex tracking assay for genotype determination reveals diverging genotype 2 isolates in Italian hemodialysis patients [In Process Citation] J. Clin. Microbiol., January 1, 1998; 36(1): 227 - 233. [Abstract] [Full Text]
|
|
|
|
 |
|
 X. Forns, J. Bukh, R. H. Purcell, and S. U. Emerson How Escherichia coli can bias the results of molecular cloning: Preferential selection of defective genomes of hepatitis C virus during the cloning procedure PNAS, December 9, 1997; 94(25): 13909 - 13914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato Mutations in the Nonstructural Protein 5a Gene and Response to Interferon in Patients with Chronic Hepatitis C Virus 1b Infection N. Engl. J. Med., January 11, 1996; 334(2): 77 - 82. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
